Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 5 studies | 24% ± 10% | |
| endothelial cell | 4 studies | 28% ± 10% | |
| glutamatergic neuron | 4 studies | 33% ± 10% | |
| microglial cell | 3 studies | 18% ± 1% | |
| epithelial cell | 3 studies | 23% ± 6% | |
| GABAergic neuron | 3 studies | 38% ± 6% | |
| astrocyte | 3 studies | 36% ± 13% | |
| interneuron | 3 studies | 39% ± 12% | |
| oligodendrocyte precursor cell | 3 studies | 25% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 6 studies | 28% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 4783.49 | 1445 / 1445 | 100% | 38.14 | 183 / 183 |
| prostate | 100% | 5260.04 | 245 / 245 | 100% | 50.20 | 501 / 502 |
| brain | 100% | 4026.48 | 2640 / 2642 | 100% | 64.33 | 704 / 705 |
| breast | 100% | 5233.00 | 459 / 459 | 99% | 45.46 | 1112 / 1118 |
| thymus | 100% | 5760.50 | 653 / 653 | 99% | 46.07 | 601 / 605 |
| lung | 100% | 5063.45 | 578 / 578 | 99% | 33.56 | 1147 / 1155 |
| intestine | 100% | 4939.15 | 966 / 966 | 99% | 29.98 | 522 / 527 |
| bladder | 100% | 5174.33 | 21 / 21 | 99% | 31.12 | 499 / 504 |
| stomach | 100% | 3838.56 | 359 / 359 | 99% | 29.18 | 283 / 286 |
| pancreas | 100% | 2347.68 | 328 / 328 | 99% | 34.31 | 176 / 178 |
| adrenal gland | 100% | 2978.54 | 258 / 258 | 98% | 39.61 | 225 / 230 |
| uterus | 100% | 7471.08 | 170 / 170 | 98% | 36.92 | 449 / 459 |
| ovary | 100% | 6778.76 | 180 / 180 | 98% | 25.06 | 420 / 430 |
| skin | 100% | 4067.53 | 1808 / 1809 | 98% | 29.25 | 461 / 472 |
| kidney | 100% | 2621.70 | 89 / 89 | 97% | 25.61 | 870 / 901 |
| liver | 99% | 1337.62 | 223 / 226 | 74% | 11.35 | 299 / 406 |
| adipose | 100% | 4586.35 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 5083.77 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 3667.02 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 4427.63 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 37.00 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 20.77 | 1 / 1 |
| heart | 100% | 3300.32 | 860 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 98% | 25.63 | 78 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 79% | 18.46 | 23 / 29 |
| peripheral blood | 77% | 1365.05 | 713 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0061188 | Biological process | negative regulation of rDNA heterochromatin formation |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0006482 | Biological process | protein demethylation |
| GO_0001889 | Biological process | liver development |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0045815 | Biological process | transcription initiation-coupled chromatin remodeling |
| GO_0005730 | Cellular component | nucleolus |
| GO_0000776 | Cellular component | kinetochore |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0035064 | Molecular function | methylated histone binding |
| GO_0032454 | Molecular function | histone H3K9 demethylase activity |
| GO_0003712 | Molecular function | transcription coregulator activity |
| GO_0032452 | Molecular function | histone demethylase activity |
| GO_0005506 | Molecular function | iron ion binding |
| GO_0008270 | Molecular function | zinc ion binding |
| GO_0035575 | Molecular function | histone H4K20 demethylase activity |
| GO_0003713 | Molecular function | transcription coactivator activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PHF2 |
| Protein name | PHD finger protein 2 PHF2 protein Lysine-specific demethylase PHF2 (EC 1.14.11.-) (GRC5) (PHD finger protein 2) |
| Synonyms | CENP-35 KIAA0662 GRC5 |
| Description | FUNCTION: Lysine demethylase that demethylates both histones and non-histone proteins . Enzymatically inactive by itself, and becomes active following phosphorylation by PKA: forms a complex with ARID5B and mediates demethylation of methylated ARID5B . Demethylation of ARID5B leads to target the PHF2-ARID5B complex to target promoters, where PHF2 mediates demethylation of dimethylated 'Lys-9' of histone H3 (H3K9me2), followed by transcription activation of target genes . The PHF2-ARID5B complex acts as a coactivator of HNF4A in liver. PHF2 is recruited to trimethylated 'Lys-4' of histone H3 (H3K4me3) at rDNA promoters and promotes expression of rDNA . Involved in the activation of toll-like receptor 4 (TLR4)-target inflammatory genes in macrophages by catalyzing the demethylation of trimethylated histone H4 lysine 20 (H4K20me3) at the gene promoters (By similarity). . |
| Accessions | Q8N359 Q6P2C5 ENST00000375376.8 A0A087WW48 ENST00000359246.9 ENST00000610682.1 O75151 E7ET14 |